Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zymergen revenue
Zymergen's revenue is $16.7 million.
What is Zymergen's revenue?
- Zymergen's revenue growth from 2020 to 2021 is 26.04%.
- Zymergen has 800 employees, and the revenue per employee ratio is $20,928.
- Zymergen's peak quarterly revenue was $5.9M in 2020(q4).
- Zymergen peak revenue was $16.7M in 2021.
- Zymergen annual revenue for 2021 was 16.7M, 26.04% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Zymergen financial information
| CEO | Jay T. Flatley |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 800 |
| Date Founded | 2013 |
| Headquarters | Emeryville, California |
| Number of Locations | 6 |
| Revenue | $16.7M |
| Net Income | -$361,785,000 |
| Gross Proft | ($53.0M) (2021) |
| Tax Rate | -0.0% |
| Total Assets | $522,396,000 |
| Ticker | ZY |
Zymergen jobs you might like
Zymergen financing
Zymergen received early financing of $2.0M on 2014-01-01.
| Series | Round size | Date |
|---|---|---|
| Seed | $2M | 01/2014 |
| Series A | $42.1M | 06/2015 |
| Series B | $130M | 10/2016 |
| Series C | $400M | 12/2018 |
| Debt Financing | $100M | 01/2020 |
| Series D | $300M | 09/2020 |
Zymergen investors
| Investors | Security type |
|---|---|
| Genoa Ventures LLC | Seed |
| Jesse Robbins | Seed |
| Jenny Rooke | Seed |
| Linden Mobile Ventures | Seed |
| Josh Perfetto | Seed |
| David Beyer | Seed |
| DCVC | Series A |
| Two Sigma Ventures | Series A |
| SciFi VC | Series A |
| Genoa Ventures LLC | Series A |
| True Ventures | Series A |
| AME Cloud Ventures | Series A |
| Obvious Ventures | Series A |
| Innovation Endeavors | Series A |
| Threshold | Series A |
| Tao Capital Partners | Series B |
| DCVC | Series B |
| SoftBank | Series B |
| Two Sigma | Series B |
| Prelude Ventures | Series B |
| AME Cloud Ventures | Series B |
| Obvious Ventures | Series B |
| ICONIQ Capital | Series B |
| Innovation Endeavors | Series B |
| Threshold | Series B |
| The Goldman Sachs Group, Inc. | Series C |
| Two Sigma Ventures | Series C |
| DCVC | Series C |
| Cota Capital | Series C |
| Hanwha Asset Management Co Ltd | Series C |
| SoftBank Investment Advisers | Series C |
| True Ventures | Series C |
| Innovation Endeavors | Series C |
| Mission BioCapital | Series C |
| Threshold | Series C |
| Trans-Pacific Technology Fund | Series C |
| Armentum Partners | Debt Financing |
| DCVC | Series D |
| Baron Capital | Series D |
| SoftBank Investment Advisers | Series D |
| True Ventures | Series D |
| Baillie Gifford | Series D |
| Perceptive Advisors | Series D |
Search for jobs
Zymergen highest paying jobs
Zippia gives an in-depth look into the details of Zymergen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Zymergen. The employee data is based on information from people who have self-reported their past or current employments at Zymergen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Zymergen. The data presented on this page does not represent the view of Zymergen and its employees or that of Zippia.
Zymergen may also be known as or be related to ZYMERGEN INC., Zymergen, Zymergen Inc, Zymergen Inc. and Zymergen, Inc.